Chargement en cours...
Outcomes of Trastuzumab Therapy for 6 and 12 Months in Indonesian National Health Insurance System Clients with Operable HER2-Positive Breast Cancer
OBJECTIVE: The aim of this study is to determine the outcome of trastuzumab therapy for 6 or 12 months in patients with HER2 positive operable breast cancer who followed the national health insurance system in Indonesia. METHODS: Data were extracted from medical records of Dr. M Djamil General Hospi...
Enregistré dans:
| Publié dans: | Asian Pac J Cancer Prev |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
West Asia Organization for Cancer Prevention
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5494230/ https://ncbi.nlm.nih.gov/pubmed/28548467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2017.18.4.1151 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|